Tracking B cell responses to the SARS-CoV-2 mRNA-1273 vaccine

被引:11
|
作者
de Assis, Felipe Lopes
Hoehn, Kenneth B. [2 ]
Zhang, Xiaozhen [1 ]
Kardava, Lela [1 ]
Smith, Connor D. [1 ]
El Merhebi, Omar [1 ]
Buckner, Clarisa M. [1 ]
Trihemasava, Krittin [1 ]
Wang, Wei [1 ]
Seamon, Catherine A. [1 ]
Chen, Vicky [3 ]
Schaughency, Paul [3 ]
Cheung, Foo [4 ]
Martins, Andrew J. [5 ]
Chiang, Chi-, I [6 ]
Li, Yuxing [6 ,7 ,8 ]
Tsang, John S. [4 ,5 ]
Chun, Tae-Wook [1 ]
Kleinstein, Steven H. [2 ,9 ,10 ]
Moir, Susan [1 ]
机构
[1] Natl Inst Allergy & Infect Dis, Lab Immunoregulat, NIH, Bethesda, MD 20892 USA
[2] Yale Sch Med, Dept Pathol, New Haven, CT 06520 USA
[3] Natl Inst Allergy & Infect Dis, Integrated Data Sci Sect, Res Technol Branch, NIH, Bethesda, MD 20892 USA
[4] NIH Ctr Human Immunol, NIAID, NIH, Bethesda, MD 20892 USA
[5] NIAID, Multiscale Syst Biol Sect, Lab Immune Syst Biol, NIH, Bethesda, MD 20892 USA
[6] Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA
[7] Univ Maryland, Dept Microbiol & Immunol, Sch Med, Baltimore, MD 21201 USA
[8] Univ Maryland, Ctr Biomol Therapeut, Sch Med, Baltimore, MD 21201 USA
[9] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06511 USA
[10] Yale Sch Med, Dept Immunobiol, New Haven, CT 06520 USA
来源
CELL REPORTS | 2023年 / 42卷 / 07期
关键词
MEMORY; IMMUNOGLOBULIN; REVEALS;
D O I
10.1016/j.celrep.2023.112780
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Protective immunity following vaccination is sustained by long-lived antibody-secreting cells and resting memory B cells (MBCs). Responses to two-dose SARS-CoV-2 mRNA-1273 vaccination are evaluated longi-tudinally by multimodal single-cell analysis in three infection-naive individuals. Integrated surface protein, transcriptomics, and B cell receptor (BCR) repertoire analysis of sorted plasmablasts and spike+ (S-2P+) and S -2P- B cells reveal clonal expansion and accumulating mutations among S-2P+ cells. These cells are enriched in a cluster of immunoglobulin G-expressing MBCs and evolve along a bifurcated trajectory rooted in CXCR3+ MBCs. One branch leads to CD11c+ atypical MBCs while the other develops from CD71+ activated precursors to resting MBCs, the dominant population at month 6. Among 12 evolving S-2P+ clones, several are populated with plasmablasts at early timepoints as well as CD71+ activated and resting MBCs at later timepoints, and display intra-and/or inter-cohort BCR convergence. These relationships suggest a coordi-nated and predictable evolution of SARS-CoV-2 vaccine-generated MBCs.
引用
收藏
页数:23
相关论文
共 50 条
  • [1] Skin reactions to mRNA-1273 SARS-CoV-2 vaccine
    Wang, Ruei-Lin
    Huang, Li-Yen
    Yang, Chung-Chi
    Hsieh, Chung-Yueh
    Wu, Kuo-An
    Chan, Jenq-Shyong
    Wu, Kun-Lin
    Shyu, Hann-Yen
    Kao, Yung-Hsi
    Shang, Shih-Ta
    Hsiao, Po-Jen
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2022, 115 (12) : 878 - 878
  • [2] Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
    Baden, Lindsey R.
    El Sahly, Hana M.
    Essink, Brandon
    Kotloff, Karen
    Frey, Sharon
    Novak, Rick
    Diemert, David
    Spector, Stephen A.
    Rouphael, Nadine
    Creech, C. Buddy
    McGettigan, John
    Khetan, Shishir
    Segall, Nathan
    Solis, Joel
    Brosz, Adam
    Fierro, Carlos
    Schwartz, Howard
    Neuzil, Kathleen
    Corey, Larry
    Gilbert, Peter
    Janes, Holly
    Follmann, Dean
    Marovich, Mary
    Mascola, John
    Polakowski, Laura
    Ledgerwood, Julie
    Graham, Barney S.
    Bennett, Hamilton
    Pajon, Rolando
    Knightly, Conor
    Leav, Brett
    Deng, Weiping
    Zhou, Honghong
    Han, Shu
    Ivarsson, Melanie
    Miller, Jacqueline
    Zaks, Tal
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (05): : 403 - 416
  • [3] SARS-CoV-2: Efficacy and Safety of the mRNA-1273 Vaccine
    Metzger, Leandra
    PNEUMOLOGIE, 2022, 76 (03): : 154 - 154
  • [4] Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents
    Ali, Kashif
    Berman, Gary
    Zhou, Honghong
    Deng, Weiping
    Faughnan, Veronica
    Coronado-Voges, Maria
    Ding, Baoyu
    Dooley, Jacqueline
    Girard, Bethany
    Hillebrand, William
    Pajon, Rolando
    Miller, Jacqueline M.
    Leav, Brett
    McPhee, Roderick
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (24): : 2241 - 2251
  • [5] A short discussion about the SARS-CoV-2 mRNA-1273 vaccine
    Oronsky, Bryan
    Gruber, Harry E.
    Reiners, Wendy
    Reid, Tony R.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 104 : 532 - 533
  • [6] Skin reactions to mRNA-1273 SARS-CoV-2 vaccine Reply
    Kano, Y.
    Kasami, S.
    Murata, K.
    Kato, M.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2022, 115 (12) : 879 - 879
  • [7] Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination
    Widge, Alicia T.
    Rouphael, Nadine G.
    Jackson, Lisa A.
    Anderson, Evan J.
    Roberts, Paul C.
    Makhene, Mamodikoe
    Chappell, James D.
    Denison, Mark R.
    Stevens, Laura J.
    Pruijssers, Andrea J.
    McDermott, Adrian B.
    Flach, Britta
    Lin, Bob C.
    Doria-Rose, Nicole A.
    O'Dell, Sijy
    Schmidt, Stephen D.
    Neuzil, Kathleen M.
    Bennett, Hamilton
    Leav, Brett
    Makowski, Mat
    Albert, Jim
    Cross, Kaitlyn
    Edara, Venkata-Viswanadh
    Floyd, Katharine
    Suthar, Mehul S.
    Buchanan, Wendy
    Luke, Catherine J.
    Ledgerwood, Julie E.
    Mascola, John R.
    Graham, Barney S.
    Beigel, John H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (01): : 80 - +
  • [8] Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
    Anderson, E. J.
    Rouphael, N. G.
    Widge, A. T.
    Jackson, L. A.
    Roberts, P. C.
    Makhene, M.
    Chappell, J. D.
    Denison, M. R.
    Stevens, L. J.
    Pruijssers, A. J.
    McDermott, A. B.
    Flach, B.
    Lin, B. C.
    Doria-Rose, N. A.
    O'Dell, S.
    Schmidt, S. D.
    Corbett, K. S.
    Swanson, P. A., II
    Padilla, M.
    Neuzil, K. M.
    Bennett, H.
    Leav, B.
    Makowski, M.
    Albert, J.
    Cross, K.
    Edara, V. V.
    Floyd, K.
    Suthar, M. S.
    Martinez, D. R.
    Baric, R.
    Buchanan, W.
    Luke, C. J.
    Phadke, V. K.
    Rostad, C. A.
    Ledgerwood, J. E.
    Graham, B. S.
    Beigel, J. H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (25): : 2427 - 2438
  • [9] Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase
    El Sahly, H. M.
    Baden, L. R.
    Essink, B.
    Doblecki-Lewis, S.
    Martin, J. M.
    Anderson, E. J.
    Campbell, T. B.
    Clark, J.
    Jackson, L. A.
    Fichtenbaum, C. J.
    Zervos, M.
    Rankin, B.
    Eder, F.
    Feldman, G.
    Kennelly, C.
    Han-Conrad, L.
    Levin, M.
    Neuzil, K. M.
    Corey, L.
    Gilbert, P.
    Janes, H.
    Follmann, D.
    Marovich, M.
    Polakowski, L.
    Mascola, J. R.
    Ledgerwood, J. E.
    Graham, B. S.
    August, A.
    Clouting, H.
    Deng, W.
    Han, S.
    Leav, B.
    Manzo, D.
    Pajon, R.
    Schodel, F.
    Tomassini, J. E.
    Zhou, H.
    Miller, J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (19): : 1774 - 1785
  • [10] Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
    Evan J Anderson
    四川生理科学杂志, 2020, 42 (04) : 468 - 468